1263102-06-2

Basic information

• Product Name: (1S,6S)-4,6-dimethylcyclohex-3-ene-carboxylic acid [5-(3,3-dimethylbut-1-ynyl)thiophen-3-yl]-(1,4-dioxa-spiro[4.5]dec-8-yl)amide
• Synonyms: (1S,6S)-4,6-dimethylcyclohex-3-ene-carboxylic acid [5-(3,3-dimethylbut-1-ynyl)thiophen-3-yl]-(1,4-dioxa-spiro[4.5]dec-8-yl)amide
• CAS NO: 1263102-06-2
• Molecular Weight: 455.662
• Mol File: 1263102-06-2.mol

Chemical Properties

• CAS DataBase Reference: (1S,6S)-4,6-dimethylcyclohex-3-ene-carboxylic acid [5-(3,3-dimethylbut-1-ynyl)thiophen-3-yl]-(1,4-dioxa-spiro[4.5]dec-8-yl)amide(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,6S)-4,6-dimethylcyclohex-3-ene-carboxylic acid [5-(3,3-dimethylbut-1-ynyl)thiophen-3-yl]-(1,4-dioxa-spiro[4.5]dec-8-yl)amide(1263102-06-2)
• EPA Substance Registry System: (1S,6S)-4,6-dimethylcyclohex-3-ene-carboxylic acid [5-(3,3-dimethylbut-1-ynyl)thiophen-3-yl]-(1,4-dioxa-spiro[4.5]dec-8-yl)amide(1263102-06-2)

Safety Data

• Hazardous Substances Data: 1263102-06-2(Hazardous Substances Data)

Upstream product

• 1263102-05-1 [5-(3,3-dimethylbut-1-ynyl)thiophen-3-yl]-(1,4-dioxaspiro[4.5]dec-8-yl)amine 
• 1314795-31-7 C₉H₁₃ClO 
• 172821-14-6 (1S,6S)-4,6-dimethyl-cyclohex-3-enecarboxylic acid 
• 90719-43-0 (4S)-3-((4'S,5'S)-1',5'-dimethylcyclohexene-4'-carbonyl)-4-(phenylmethyl)-2-oxazolidinone 
• 172821-14-6 (6S)-4,6-dimethyl-cyclohex-3-enecarboxylic acid 

Downstream Products

• 1263102-08-4 (1S,6S)-4,6-dimethyl-cyclohex-3-ene-carboxylic acid [5-(3,3-dimethyl-but-1-ynyl)-thiophen-3-yl]-(trans-4-hydroxy-cyclohexyl)-amide 
• 1263102-04-0 5-(3,3-dimethyl-but-1-ynyl)-3-[(1S,6S)-(4,6-dimethyl-cyclohex-3-enecarbonyl)-(4-hydroxy-cyclohexyl)-amino]-thiophene-2-carboxylic acid 

Relevant articles and documents

THIOPHEN-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS INHIBITORS OF FLAVIVIRIDAE VIRUSES

Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections (e.g. hepatitis C infections), particularly drug

INHIBITORS OF FLAVIVIRIDAE VIRUSES

Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.

INHIBITORS OF FLAVIVIRIDAE VIRUSES

Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.